Medtronic (NYSE:MDT) announced today that it was one of three recipients of the 2020 Catalyst Award in recognition of the its initiatives for fostering a workplace in which women can advance. The medtech giant said it is being recognized by Catalyst, a nonprofit seeking to build “workplaces that work for women,” for its Medtronic Women’s Network […]
Business/Financial News
Wall Street Beat | Earnings Reports | Funding Roundup | Mergers & Acquisitions | Initial Public Offerings | Legal News
Proteus pivots, hands digital mental health adherence business to Otsuka
Proteus Digital Health is abandoning its mental illness and cardiovascular work in its digital pill technology after its deal with Otsuka Pharmaceutical (TYO:4578) ended prematurely and will start to focus more on therapeutic areas, STAT News reports. Otsuka Pharmaceutical had been paying Proteus to develop a portfolio of digital medicines for serious mental health conditions. […]
Embody lands $2.5m from DARPA
Soft-tissue repair treatment developer Embody announced that it has landed a $2.5 million grant from the Defense Advanced Research Projects Agency (DARPA). The latest DARPA funding brings Norfolk, Va.-based Embody’s total DARPA non-dilutive funding to nearly $14.4 million, according to a news release. Embody plans to use the Phase II Small Business Innovation Research (SBIR) […]
ResMed settles kickback allegations for $37.5 million
This article has been updated with comments from ResMed. ResMed (NYSE:RMD) has agreed to pay more than $37.5 million to settle five whistleblower lawsuits claiming the company paid kickbacks to doctors, sleep labs and medical equipment suppliers to obtain customer referrals, according to the U.S. Department of Justice. Federal prosecutors alleged that San Diego-based ResMed: […]
Tandem Diabetes Care launches t:slim X2 with Control-IQ in U.S.
Tandem Diabetes Care (NSDQ:TNDM) announced today that it began the U.S. commercial launch of its t:slim X2 insulin pump with Control-IQ advanced hybrid closed-loop technology. In December, the San Diego-based company announced that the FDA cleared the t:slim X2 insulin pump and Control-IQ technology for controlling Type 1 diabetes, touting it as the first and only system cleared […]
Reva Medical files for bankruptcy
Reva Medical (ASX:RVA) announced today that it has filed for Chapter 11 bankruptcy protection. San Diego-based Reva — which specializes in bioresorbable polymer tech for vascular applications — entered into a restructuring support agreement with a handful of its stakeholders last month. The goal was to address the company’s outstanding debt. Reva also filed a prepackaged […]
Zebra Medical Vision appoints new CEO, seeks to grow in U.S.
Zebra Medical Vision announced that it appointed Ohad Arazi as its new CEO as the company as it looks to expand its footprint in the U.S. Arazi’s appointment is set to be made effective on March 1, 2020, at which point he will succeed Zebra co-founder Eyal Gura, who will continue as board chairman. Arazi […]
Synaptive Medical updates Modus V surgical microscope
Synaptive Medical announced that its U.S. and Canadian Modus V robotic digital microscope now includes updates such as additional 3D visualization and voice-activated control. The Modus V is a robotically controlled digital microscope used as part of Synaptive’s BrightMatter surgical suite designed for less invasive, patient-specific approaches in complex cranial procedures. The Modus V provides […]
Smile Direct Club aligners now available in-office; stock soars
SmileDirectClub (NSDQ:SDC) shares skyrocketed following the announcement that its clear aligners are set to be offered through the wholesale channel in dentist and orthodontist offices. The Nashville, Tenn.-based company’s announcement follows the Dec. 31, 2019, expiration of its exclusive supply agreement with Align Technology (NSDQ:ALGN). After yesterday’s announcement, shares of SDC are up 16.24% at $13.60 per […]
T2 Biosystems names new chief commercial officer
T2 Biosystems (NSDQ:TTOO) this week appointed Tony Pare as chief commercial officer, effective immediately. Pare previously served as VP and general manager of international at the company. The chief commercial officer role was a newly created position within T2 Biosystems. “I am delighted to appoint Tony as our chief commercial offer and look forward to working […]
Haemonetics buys hemostasis analyzer IP
Haemonetics (NYSE:HAE) announced today that it purchased the technology underlying the TEG 6s hemostasis analyzer system from CoraMed Technologies. Braintree, Mass.-based Haemonetics now owns the intellectual property it previously licensed from CoraMed for use in hospitals and hospital laboratories, and may pursue site-of-care opportunities beyond hospitals. TEG 6s includes an analyzer, disposable cartridges and software designed […]